Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US29479A1088
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00MTSR883
ERAS
Erasca Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Erasca Inc
ISIN
US29479A1088
TICKER
ERAS
MIC
XNAS
REUTERS
ERAS.OQ
BLOOMBERG
ERAS US
Sa., 25.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 25.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 24, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       Erasca
US29479A1088

BENSALEM, Pa., July 24, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ERASCA, INC. (ERAS), CONTACT THE LAW OFFIC...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) on behalf of investors that purchased or otherwise acquired Erasca securities between January 14, 2025 and April 26, 2026 (the "Class Period").CLI...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       Erasca
US29479A1088

SAN DIEGO, July 24, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, both dates inclusive (the "Class Period"), have until Monday, August 10, 2026 to seek appointment as lead plaintiff of the Eras...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 24, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc. (NASDAQ: ERAS). The litigation alleges Erasca and its senior executives misled investors by providing a false narrative regarding the competitive advan...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 23, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 23.07.2026       Erasca
US29479A1088

Critical Information: ERAS Investors Lost $11.59 Per Share as Artificially Inflated Stock Price Collapsed Following Dual Corrective Disclosures on April 27-28, 2026NEW YORK, July 23, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Erasca, Inc. (NASDAQ: ERAS) securities of a pending securities class action....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       Erasca
US29479A1088

NEW YORK, July 23, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encoura...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 23, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc. (NASDAQ: ERAS). The litigation alleges Erasca and its senior executives misled investors by providing a false narrative regarding the competitive advan...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       Erasca
US29479A1088

NEW YORK, July 22, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaint...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 22.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 22, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 22.07.2026       Erasca
US29479A1088

PHILADELPHIA, July 22, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") on behalf of investors who purchased or acquired Erasca common stock during the period from January 14, 2025 through April 26, 2026 (the "Class Period")....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 22.07.2026       Erasca
US29479A1088

Erasca Allegedly Concealed Patent Infringement Risk and a Patient Death While Publicly Promoting ERAS-0015 as a "Best-in-Class" Drug Candidate, Costing Investors $11.59 Per ShareNEW YORK, July 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Erasca, Inc. (NASDAQ: ERAS) that a securities class action has been filed on behalf...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 22.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 22, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc. (NASDAQ: ERAS). The litigation alleges Erasca and its senior executives misled investors by providing a false narrative regarding the competitive advan...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 21.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 21, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc. (NASDAQ: ERAS). The litigation alleges Erasca and its senior executives misled investors by providing a false narrative regarding the competitive advan...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 21.07.2026       Erasca
US29479A1088

LOS ANGELES, July 21, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 21.07.2026       Erasca
US29479A1088

NEW YORK, July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Erasca, Inc. (NASDAQ: ERAS). Shareholders who purchased shares of ERAS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appoint...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 21.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 20.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 20.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 20.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 20, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 20.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 20, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) on behalf of investors that purchased or otherwise acquired Erasca securities between January 14, 2025 and April 26, 2026 (the "Class Period").CLI...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 20.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
So., 19.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 18.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 18.07.2026       Erasca
US29479A1088

NEW YORK, July 17, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plainti...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 17.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 17, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) on behalf of investors that purchased or otherwise acquired Erasca securities between January 14, 2025 and April 26, 2026 (the "Class Period").CLI...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 17.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 17.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 17.07.2026       Erasca
US29479A1088

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients wi...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 17.07.2026       Erasca
US29479A1088

San Diego, California--(Newsfile Corp. - July 17, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, all dates inclusive (the "Class Period"), have until Monday, August 10, 2026 to seek appointment as lead plaintiff of the Erasc...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 16.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 16.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 16, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 16.07.2026       Erasca
US29479A1088

Erasca's repeated preclinical comparisons to Revolution Medicines' RMC-6236 were allegedly improper and placed the company at risk of patent and trade secret violations, costing investors over $11 per share when the truth emerged.NEW YORK, July 16, 2026 /PRNewswire/ -- SueWallSt notifies investors in Erasca, Inc. (NASDAQ: ERAS) that a class action...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 16.07.2026       Erasca
US29479A1088

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encourage...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 16.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 16, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc. (NASDAQ: ERAS). The litigation alleges Erasca and its senior executives misled investors by providing a false narrative regarding the competitive advan...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 16.07.2026       Erasca
US29479A1088

SAN DIEGO, July 15, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), have until Monday, August 10, 2026 to seek appointment as lead plaintiff of the Erasca class action lawsuit. Ca...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 15.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 15.07.2026       Erasca
US29479A1088

Erasca Allegedly Raised $258.8 Million Through a Shelf Registration Statement While Concealing Patent Infringement Risk and Improper Preclinical Comparisons for Its Lead Drug CandidateNEW YORK, July 15, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class action has been filed against Erasca, Inc. (NASDAQ: ERAS)....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 15.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month after receiving...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 14.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 14.07.2026       Erasca
US29479A1088

LOS ANGELES, July 14, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ:ERAS). IF YOU SUFFERED A LOSS ON YOUR ERAS...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 14.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 14, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 14.07.2026       Erasca
US29479A1088

NEW YORK, July 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Erasca, Inc. (NASDAQ: ERAS). Shareholders who purchased shares of ERAS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appoint...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 14.07.2026       Erasca
US29479A1088

Philadelphia, Pennsylvania--(Newsfile Corp. - July 14, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") on behalf of investors who purchased or acquired Erasca common stock during the period from January 14, 2025 through April 26, 2026 (the "Cla...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 14.07.2026       Erasca
US29479A1088

SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public offering of 31,428,572 shares of its common stock. Th...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink